| DIRECT COMPETITOR COMPARISON | |
| VRX | Pvt1 | NVS | RHHBY.PK | Industry | | Market Cap: | 2.56B | N/A | 119.37B | N/A | 175.18M | | Employees: | 2,331 | N/A | 99,000 | N/A | 94 | | Qtrly Rev Growth (yoy): | 30.80% | N/A | 2.40% | N/A | 20.50% | | Revenue (ttm): | 772.95M | N/A | 42.31B | N/A | 46.74M | | Gross Margin (ttm): | 75.52% | N/A | 72.61% | N/A | 56.06% | | EBITDA (ttm): | 300.35M | N/A | 11.24B | N/A | -7.12M | | Oper Margins (ttm): | 28.93% | N/A | 21.50% | N/A | 2.25% | | Net Income (ttm): | -32.02M | N/A | 7.59B | N/A | N/A | | EPS (ttm): | -0.640 | N/A | 3.34 | N/A | -0.17 | | P/E (ttm): | N/A | N/A | 15.74 | N/A | 18.97 | | PEG (5 yr expected): | 0.85 | N/A | 2.79 | 1.45 | 1.02 | | P/S (ttm): | 3.32 | N/A | 2.82 | N/A | 4.44 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.22 | 0.00% | 57.91B | 12.48 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 53.38 | 0.00% | 15.44B | 17.86 | | Genzyme Corp. | GENZ | 48.24 | 0.00% | 12.80B | 27.50 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.26 | 0.00% | 38.93B | 16.73 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.57 | 0.00% | 9.20B | 1052.45 | | Teva Pharmaceutical Industries Limited | TEVA | 57.06 | 0.00% | 50.27B | 52.20 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.89 | 0.00% | 4.23B | 20.56 | | King Pharmaceuticals Inc. | KG | 12.54 | 0.00% | 3.11B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.52 | 0.00% | 5.66B | 113.62 | | Pfizer Inc. | PFE | 18.66 | 0.00% | 150.58B | 15.50 | | Johnson & Johnson | JNJ | 63.93 | 0.00% | 176.39B | 13.96 | | GlaxoSmithKline plc | GSK | 41.83 | 0.00% | 106.04B | 13.58 | | Sanofi-Aventis | SNY | 40.30 | 0.00% | 105.23B | N/A | | Novartis AG | NVS | 52.56 | 0.00% | 119.37B | 15.74 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.24 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.45 | 0.00% | 67.35B | 9.33 | | Abbott Laboratories | ABT | 54.02 | 0.00% | 83.55B | 14.64 | | Bristol-Myers Squibb Co. | BMY | 25.23 | 0.00% | 49.98B | 13.05 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|